Skip to main content

Table 3 Several metabolic and inflammatory parameters observed in the whole group of DTC subjects and in controls.

From: Metabolic and cardiovascular risk in patients with a history of differentiated thyroid carcinoma: A case-controlled cohort study

  DTC subjects Control subjects Significance
Glucose (mmol/L) 4.7 ± 0.1 4.9 ± 0.1 ns
Insulin (mU/L) 8.5 ± 0.5 7.7 ± 0.6 P = 0.05
HOMA-IR [(mU × mmol)/22.5] 1.85 ± 0.13 1.74 ± 0.17 ns
HbA1c (%) 5.7 ± 0.1 5.7 ± 0.1 ns
Cholesterol (mmol/L) 5.36 ± 0.10 5.51 ± 0.11 ns
HDL-cholesterol (mmol/L) 1.71 ± 0.04 2.04 ± 0.09 P = 0.01
LDL-cholesterol (mmol/L) 3.11 ± 0.09 2.93 ± 0.11 ns
Triglycerides (mmol/L) 1.26 ± 0.06 1.21 ± 0.07 ns
CRP (mg/l) 4.4 ± 0.4 4.2 ± 0.3 ns
Fibrinogen (g/L) 355 ± 6 363 ± 10 ns
  1. Data are reported as mean ± SEM.